Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Nephros (NEPH) over the last 12 years, with Q3 2025 value amounting to $312000.0.

  • Nephros' Change in Account Payables rose 14073.11% to $312000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $545000.0, marking a year-over-year increase of 23325.18%. This contributed to the annual value of -$220000.0 for FY2024, which is 26541.35% down from last year.
  • According to the latest figures from Q3 2025, Nephros' Change in Account Payables is $312000.0, which was up 14073.11% from $81000.0 recorded in Q2 2025.
  • Over the past 5 years, Nephros' Change in Account Payables peaked at $685000.0 during Q4 2021, and registered a low of -$766000.0 during Q3 2024.
  • Moreover, its 5-year median value for Change in Account Payables was $68000.0 (2023), whereas its average is $27157.9.
  • As far as peak fluctuations go, Nephros' Change in Account Payables plummeted by 67500.0% in 2022, and later skyrocketed by 126190.48% in 2024.
  • Over the past 5 years, Nephros' Change in Account Payables (Quarter) stood at $685000.0 in 2021, then tumbled by 105.55% to -$38000.0 in 2022, then soared by 278.95% to $68000.0 in 2023, then surged by 277.94% to $257000.0 in 2024, then increased by 21.4% to $312000.0 in 2025.
  • Its last three reported values are $312000.0 in Q3 2025, $81000.0 for Q2 2025, and -$105000.0 during Q1 2025.